LATEST NEWS

Welcome Saúde 2019- the event that presented the political and economic perspectives for the health

Date: 01/31/2019

On January 29th, Domo Salute attended the event “Welcome Saúde 2019”, organized by Media Group to welcome the health sector this year. The event discussed the political and economic perspectives for the sector and brought experts and authorities from different links in the health chain.

A survey conducted by Media Group noted that 55% of respondents believe that the current government will be good for the sector and also indicated a perspective of growth of the health sector for this year.

The talk, made by Mauro Junqueira, President of Conasems, addressed the dimensions and challenges of the Unified Health System (SUS). Mauro Junqueira defended the SUS despite understanding that there is a great opportunity for improvement in the execution of the services provided by the SUS.

The second lecture, given by Ricardo Valentim, from Lais – Laboratory of Technological Innovation in Health, covered Humanitarian Health and showed an analysis on primary care. Ricardo Valentim defends the idea of ​​developing an anti-disciplinary leadership model, which is not hierarchical yet horizontal and focused on solving problems, which makes the system more resilient and responsive. He said, “A well-solved problem in Brazil may have a scale of world-wide resolution.”

After the two talks, the roundtable discussions began. “Building the future of health: the role of the protagonists of the sector in face of the new times of Brazilian politics” was the subject of the first round table of Welcome Saúde 2019(link).

The second table included New horizons: The influence of the economy in the construction of a more efficient health. The debates brought together representatives of the main links in the health chain with the presence of Mauro Junqueira, from Consems; Ricardo Valentim, Lais; Ruy Baumer, Comsaúde, Rodrigo Lopes, the Lefort Group; Alceu Alves da Silva, VP of MV; Luiz Aramicy Pinto, FBH; Claudia Cohn, Abramed; Paulo Fraccaro, Abimo; Giovanni Guido Cerri, the Radiology Institute of HCFMUSP; Marcos Marques, Abradimex; Francisco Balestrin, IHF; and Franco Pallamolla, Abimo.

We believe that initiatives and events such as Welcome Saúde 2019 promote more discussions and contribute to the development of health in the country. Entities, companies and people should take a close look at the economic and political aspects of that and contribute to the resolution of problems along with the competent bodies (such as ANVISA, for example) so that the country can well assist that which is the main focus of all discussions: the Brazilian patient.

MORE NEWS

07/18/2024
  From June 24 to 28, ANVISA participated in the MDSAP Forum and Regulatory Authority Council (RAC) meeting in Essen, Germany. The event gathered representatives from 27 countries, including regulatory authorities, MDSAP auditing organizations, and industry representatives, with notable attendance from Brazilian associations ABIMED and [...]
07/02/2024
  In force since January 2022, RDC 591/2021, which provides for the Unique Device Identification (UDI) system, was amended by ANVISA just days before the deadline for attributing and affixing UDI to risk class IV devices. The amendment was published in RDC 884/2024 on June 1, 2024, and is already in force. According to ANVISA,... Leia [...]
04/12/2024
Marking a significant advancement in regulatory reliance mechanisms, the National Health Surveillance Agency (ANVISA) published Normative Instruction (IN) 290/2024, on April 8, 2024. This normative introduces an optimized procedure for evaluating and deciding on registration petitions for medical devices previously regulated in recognized [...]
03/22/2024
Important Regulatory Update for Manufacturers under MDSAP in Brazil Today, ANVISA has announced a significant regulatory development with the publication of Resolution RDC 850/2024. This regulation brings forth a crucial amendment concerning the validity period of the Brazilian Good Manufacturing Practices (BGMP) Certificate for manufacturers [...]
01/05/2024
Collegiate Board Resolution (RDC) 837/2023, published by ANVISA on December 15th, 2023, brings updates to the rules regarding clinical investigations with medical devices performed in Brazil. Effective immediately from the publication, this resolution aligns Brazilian practices with international standards, providing clearer guidelines for [...]
12/13/2023
On 11 of December 2023, ANVISA published Collegiate Board Resolution – RDC 830/2023, addressing risk classification, registration procedures, as well as labeling requirements and instructions for use of in vitro diagnostic medical devices (IVDs) in Brazil. The new RDC, effective from June 1, 2024, is a comprehensive revision that consolidates [...]
11/28/2023
Public Consultation No. 1.208 will be open to receive contributions until December 9th. In the dynamic landscape of medical device regulations in Brazil, obtaining the Brazilian Good Manufacturing Practices (BGMP) certification is a mandatory request for manufacturers of Class III and Class IV devices seeking Registro. In a recent move towards [...]
03/01/2023
  Starting today – March 1st 2023 – the new Resolution RDC nº 751/2022  comes into force. The Resolution provides for risk classification, Notification and Registro processes, and the requirements for medical devices’ labeling and instructions for use. In order to meet the new requirements and procedures, ANVISA has already [...]
09/22/2022
The Collegiate Board Resolution – RDC 751/2022 was published on the 21st of September 2022, which provides for risk classification, Notification and Registro processes, and the requirements for medical devices’ labeling and instructions for use. The new RDC consolidates the risk classification and regularization regimes for all risk [...]